According to ProQR's latest financial reports the company's current earnings (TTM) are -$30.2 M. In 2022 the company made an earning of -$64.86 M an increase over its 2021 earnings that were of -$71.55 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$30.2 M | -53.44% |
2022 | -$64.86 M | -9.36% |
2021 | -$71.55 M | 32.55% |
2020 | -$53.98 M | -14.76% |
2019 | -$63.33 M | 45.12% |
2018 | -$43.64 M | -13.07% |
2017 | -$50.21 M | 15.97% |
2016 | -$43.29 M | 86.32% |
2015 | -$23.24 M | 45.72% |
2014 | -$15.95 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Atara Biotherapeutics ATRA | -$0.28 B | 796.86% | ๐บ๐ธ USA |
Agenus
AGEN | -$0.16 B | 428.23% | ๐บ๐ธ USA |
Actinium Pharmaceuticals ATNM | -$51.92 M | 71.94% | ๐บ๐ธ USA |